DYAI
DYAI
NASDAQ · Biotechnology

Dyadic International Inc

$0.90
+0.02 (+1.82%)
As of Jun 30, 10:45 PM ET ·
Financial Highlights (FY 2026)
Revenue
3.49M
Net Income
-8,327,916
Gross Margin
24.9%
Profit Margin
-238.3%
Rev Growth
+1.8%
D/E Ratio
4.08
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 24.9% 24.9% 60.3% 60.3%
Operating Margin -232.7% -209.5% -23.3% -23.1%
Profit Margin -238.3% -226.4% -25.2% -25.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 3.49M 3.43M 4.58M 5.07M
Gross Profit 871.1K 855.8K 2.76M 3.05M
Operating Income -8,132,880 -7,190,875 -1,067,325 -1,170,649
Net Income -8,327,916 -7,363,320 -1,151,647 -1,307,679
Gross Margin 24.9% 24.9% 60.3% 60.3%
Operating Margin -232.7% -209.5% -23.3% -23.1%
Profit Margin -238.3% -226.4% -25.2% -25.8%
Rev Growth +1.8% +1.8% +24.2% +16.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 11.87M 11.87M 10.08M 8.74M
Total Equity 2.91M 2.91M 17.40M 17.52M
D/E Ratio 4.08 4.08 0.58 0.50
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -8,136,045 -7,593,322 -1,556,423 -1,763,687
Free Cash Flow -1,101,967 -1,220,171